|
|
Volumn 13, Issue 1, 1995, Pages 303-304
|
|
Multidrug-resistance modulation in metastatic breast cancer patients [4]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
DOXORUBICIN;
EPIRUBICIN;
FLUOROURACIL;
GLYCOPROTEIN P;
METHOTREXATE;
PHENOTHIAZINE DERIVATIVE;
PROGESTERONE;
QUINIDINE;
RESERPINE;
TAMOXIFEN;
VERAPAMIL;
ANALYTIC METHOD;
AREA UNDER THE CURVE;
BREAST CANCER;
CLINICAL TRIAL;
COST BENEFIT ANALYSIS;
DRUG SCREENING;
FEMALE;
HUMAN;
HUMAN TISSUE;
LETTER;
METASTASIS;
MULTIDRUG RESISTANCE;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
|
|
EID: 0028894303
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/jco.1995.13.1.303 Document Type: Letter |
|
Times cited : (5)
|
|
References (0)
|
